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مؤشر الكاحل العضدى ىف األطفال الذين يعانون متالزمة الكلوية مقاومة 
الستريويد
�صريين ع�صام ماهر حممد، عبد العظيم حممد ال�صيد املزارى ،هانى طه ع�صقالنى 
امللخ�ص: الهدف: تهدف هذة الدرا�صة اإىل تقييم موؤ�رس الكاحل الع�صدى كموؤ�رس لأمرا�ض ال�رسايني الطرفية فى الأطفال امل�صابني مبتالزمة 
الكلوية امل�صادة ال�صتريويد. الطريقة: ا�صتملت هذه الدرا�صة على ع�رسين طفال من الذين يح�رسون العيادة اخلارجية لأمرا�ض الكلى لالأطفال 
مب�صت�صفى املنيا اجلامعى ،م�رس . فى هذة الدرا�صة كان 11 من الذكور و 9 من الإناث تراوحت اأعمارهم بني 5و 15 عام و كان بهم زلل 
ال�صن كمجموعة �صابطة .تعر�ض جميع املر�صى و  20 طفال �صحيح مطابق للجن�ض و  اأخذ  . مت  بالبول و يخ�صعون للعالج بال�صتريويد 
الأ�صحاء لأخذ التاريخ املر�صى و للفح�ض ال�رسيرى . خ�صع جميع املر�صى فى هذة الدرا�صة لالختبارات املعملية مثل حتليل البول ،ن�صبة 
الربوتينات فى بول 24 �صاعة ، اليوريا والكرياتينني فى م�صل الدم ،ن�صبة اللبيومني و الكال�صيوم و الف�صفور و الفو�صفات القلوي فى م�صل 
الكلوية وكذلك عمل  الكلى لت�صخي�ض نوع املر�ض فى متالزمة  اأخذ خزعة من  . مت  الكولي�صتريول  الثالثية و  الدهون  الدم ،و كذلك ن�صبة 
درا�صة دوبلر لتحديد موؤ�رس الكاحل الع�صدي . النتائج : اأظهرت النتائج ان موؤ�رس الكاحل الع�صدي كان اأعلى بكثري فى جمموعة املر�صى 
عن املجموعة ال�صابطة ، و كان هناك ارتباط اإيجابي بني موؤ�رس الكاحل الع�صدي و جرعة ال�صتريويد و مدة العالج .  اخلال�صة : انتهت 
الدرا�صة اإىل اأن موؤ�رس الكاحل الع�صدي طريقة ب�صيطة للتنبوؤ بت�صلب ال�رسايني فى الأطفال امل�صابني مبتالزمة الكلوية امل�صادة ال�صتريويد 
لفرتة طويلة.
مفتاح الكلمات: موؤ�رس الكاحل الع�صدي، الأطفال، مقاومة ال�صتريويد، متالزمة الكلوية، م�رس. 
abstract: Objectives: This study aimed to assess the ankle brachial index (ABI) as a predictor of peripheral 
arterial diseases (PAD) in children with steroid-resistant nephrotic syndrome (NS). Methods: Twenty children 
(11 males and 9 females) attending the Pediatric Nephrology Outpatient Clinic of El-Minia University Hospital, 
Egypt, were enrolled in this study. Their age ranged between 5 and 15 years with a mean of 10.75 ± 3.31 years. They 
had proteinuria and were dependent on steroid therapy. Twenty healthy age- and sex-matched children served 
as a control group. All patients and controls underwent a thorough history-taking and clinical examination. All 
subjects in the study underwent laboratory investigations, including a urine analysis (24-hour test for protein in 
urine, and levels of serum urea and creatinine, triglycerides, and cholesterol). A renal biopsy was done to diagnose 
the children’s histopathological type of NS. A Doppler study was done to determine patients’ ABI. Results: ABI 
was significantly higher in the patient group than in the control group (P <0.0001). There was a negative correlation 
between ABI and duration of treatment (r value = 0.77 and P <0.001). Conclusion: ABI is simple non-invasive 
manoeuvre that can reliably assess arterial stiffness as an early predictor of atherosclerosis in nephrotic patients 
with long duration of both illness and steroid therapy.
Keywords: Ankle brachial index; Children; Steroid resistant; Nephrotic syndrome; Egypt.
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Advances in Knowledge
- An increased risk of cardiovascular disease exists in patients with nephrotic syndrome (NS) because of hyperlipidaemia, increased 
thrombogenesis, and endothelial dysfunction. 
- Hypercholesterolaemia is strongly associated with severity of hypoalbuminemia, and persistent proteinuria or renal insufficiency also 
contributes to cardiovascular disease. 
- The risk of premature atherosclerosis is increased due to hyperlipidaemia. 
- The duration of nephrotic hyperlipidaemia appears to be critical to initiating vascular damage. 
- Endothelial damage from hyperlipidaemia may favor influx of lipoprotein into the mesangium, leading to proliferation and sclerosis. 
- Lipoproteins are elevated in children with long-standing and frequently relapsing NS. 
- They are at increased risk for developing atherosclerosis, glomerular and interstitial renal disease. 
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Patients with nephrotic syndrome (NS) are assumed to be at increased risk for peripheral arterial diseases (PAD) and 
coronary heart diseases, probably because NS is 
associated with hyperlipidaemia, hypertension 
and steroid therapy. NS is defined by the presence 
of a nephrotic range of  proteinuria, oedema, 
hyperlipidaemia, and hypoalbuminemia. Primary 
or idiopathic nephrotic syndrome (INS) is divided 
into steroid-sensitive NS and steroid-resistant 
NS because a patient’s response to steroids has 
a high correlation with histological subtype and 
prognosis.1 INS is accompanied by a disordered lipid 
metabolism. Apolipoprotein-B (apo-B)-containing 
lipoproteins are elevated with resultant increases in 
total cholesterol and low-density lipoprotein (LDL) 
cholesterol. Elevations in triglyceride levels occur 
with severe hypoalbuminaemia. The traditional 
explanation for hyperlipidaemia in INS was the 
increased synthesis of lipoproteins that accompany 
increased hepatic albumin synthesis due to 
hypoalbuminaemia.2 High mortality from chronic 
kidney disease (CKD)—due to cardiovascular 
complications, vascular calcification induced by 
excess calcium and phosphate, and uremia—is a 
major risk factor and is independently associated 
with cardiovascular events and death. CKD-
induced vascular disease causes stiffness of the 
arterial tree causing, in turn, systolic hypertension 
and left ventricular hypertrophy.3 Management of 
CKD is difficult but early detection and treatment 
are crucial to reducing cardiovascular mortality.
This study therefore aimed to assess ankle 
brachial index as a predictor of developing 
atherosclerosis in children with steroid-resistant 
nephrotic syndrome. 
Methods
Twenty patients from the Pediatric Nephrology 
Clinic of El-Minia University Hospital, Egypt, 
participated in the study, which took place between 
April and December 2010. The study was comprised 
of 11 males and 9 females with a mean of age 10.75 
± 3.31 years who had been diagnosed with steroid-
resistant NS. Their diagnosis was made according to 
the following criteria set forth by the International 
Study of Kidney Disease in Children (ISKDC): no 
urinary remission within 4 weeks of a prednisone 
therapy course of 60 mg/m2/day.4
Twenty apparently healthy children with 
no history of cardiovascular or renal diseases 
and matched by age and sex served as a control 
group. Their ages ranged between 8 and 14 years 
with a mean age of 11 ± 2.1 years. The study was 
approved by the Local Ethical Committee of El-
Minia University in Egypt and was sponsored by Dr. 
Manal Ismail. Written informed consent was 
obtained from the parents for all participating 
children.
All patients’ medical histories were taken, and 
their clinical examinations included an accurate 
and thorough measurement of arterial pressure, an 
examination of oedema, and a cardiac examination. 
None of our patients had congenital or rheumatic 
heart disease.
Laboratory investigations included: 1) urine 
analysis and urinary protein measurement; 2) blood 
tests during which about 3 ml of venous blood was 
obtained by sterile vein puncture after the patients 
had fasted for 12–14 hours (the separated serum 
was then used for assessment of serum albumin, 
urea, creatinine, alkaline phosphatase, calcium, 
phosphorus, cholesterol, and triglycerides [TG]); 
and 3) renal ultrasonography and biopsy.
The ankle brachial index (ABI) is a clinical tool 
used for the detection of peripheral arterial disease, 
which in turn predicts cardiovascular morbidity 
and mortality.5 In this study, patients were placed 
supine for at least 5 minutes. The systolic blood 
pressure of the brachial artery of both arms and 
the posterior tibial artery of both ankles were then 
measured using a blood pressure cuff and a Parks 
Model 841-A pocket Doppler probe (Parks Medical 
Application to Patient Care
- Peripheral artery disease (PAD) can be accurately diagnosed with the ankle brachial index (ABI).
- Low values of the ABI are predictive of incident cardiovascular disease (CVD), as well as total mortality. These associations hold true in 
both sexes and are independent of traditional CVD risk factors. 
- ABI is an independent newer biomarker for standard CVD risk factors. 
- ABI measurement can provide a simple and early prediction of patient with high risk of CVD and lead to better protection.
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Electronics, Aloha, Oregon, USA). The highest arm 
pressure was then used to calculate ABI. The ratio of 
ankle to arm systolic blood pressure was calculated 
for each leg, and the lowest ratio was recorded as 
the ABI. ABIs were classified as low (≤0.9), normal 
(0.91–1.3), or high (>1.3).5
Collected data were then tabulated. Numerical 
data were expressed by the mean ± standard 
deviation (SD) and categorical data were expressed 
by a number and a percentage. Statistical analysis 
was conducted by means of Statistical Package 
for Social Science (SPSS), Version 15.0 (IBM, Inc., 
Chicago, Illinois, USA) using an unpaired t-test 
for comparison of numerical data of both groups. 
A correlation-coefficient study between ABI and 
laboratory data was done, with a P value considered 
significant at <0.05.
Results
Table 1 shows a significant increase in renal 
function markers in the patient group in contrast 
to the control group, including increases in 
serum urea and creatinine (P values 0.009 and 
0.001, respectively). Also, serum phosphorus and 
alkaline phosphatase were significantly higher in 
patients versus controls, (P values 0.03 and 0.006, 
respectively). Serum albumin and serum calcium 
were significantly decreased in the patient group as 
compared with controls (P value 0.0001–0.01). For 
lipid markers, serum cholesterol was significantly 
higher in the patients than in the controls (P value 
0.0001) but there was no significant difference 
in TG levels. The ABI in the patient group was 
significantly lower (0.89 ± 0.02) than in the control 
group (1.04 ± 0.08) (P value 0.0001) [Table 2]. Also, 
there was a highly significant negative correlation 
between patients’ mean ABI scores and their 
disease duration, serum urea, serum creatinine, and 
cholesterol levels (P value <0.001). Additionally, 
there was a significant negative correlation between 
patients’ mean ABI score and serum TG (P value 
<0.02). On the other hand, there was a significant 
positive correlation between patients’ mean ABI 
scores and their serum albumin (P value <0.02) 
Table 1: Demographic and laboratory variables in 
patients and control groups
Data Patients Controls P value
Mean ± SD Mean ± SD
Age
(years)










49.0 ± 34.17 21 ± 1.4 0.009 *
Creatinine
(mg/dl)
1.13 ± 0.7 0.47 ± 0.1 0.001**
Calcium
(mg/dl)
0.96 ± 0.17 1.09± 0.01 0.01*
Phosphorus
(mg/dl)
5.06 ± 1.27 4.05 ± 0.78 0.03*
Albumin
(g/dl)




178.16 ± 109.0 81.67 ± 19.8 0.006*
Cholesterol
(mg/dl)
248.18 ± 101.7 104.7 ± 26.2 0.0001**
TG
(mg/dl)
259.4 ± 152.09 173.7 ± 22.6 0.06
SD = standard deviation; M = male; F = female; TG = triglycerides; 
* = significant; ** = highly significant.
Table 2: Comparison between patients and controls in 
regards to mean score on the ankle brachial index
Patients Controls P value
Mean ± SD Mean ± SD
ABI score 0.89 ± 0.02 1.04 ± 0.08 0.0001**
SD = standard deviation; ABI = ankle brachial index; ** = highly 
significant.
Table 3: Correlation between mean ankle brachial index 
scores and different parameters in the patient group
Parameter r-Value P Value
Disease duration (years) -0.77 <0.001*     
Urea (mg/dl) -0.74 <0.001 **    
Creatinine (mg/dl) -0.66 <0.001**
Calcium (mg/dl) -0.06 <0.7#       
Albumin (g/dl) 0.35 <0.02*      
Alkaline phosphates (u/l) -0.21 <0.2#
Cholesterol (mg/dl) -0.59 <0.0001**
TG (mg/dl) -0.45 <0.02*
 
TG = triglycerides; * = significant; ** = highly significant; # = non-
significant.
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[Table 3]. According to renal biopsy, 17 patients had 
membranoproliferative glomerulonephritis, two 
patients had focal segmental glomerulosclerosis, 
and only one patient had diffuse mesangial 
proliferation.
Discussion
Overall, approximately 10% of patients with 
INS do not respond to an initial trial of steroids. 
Additionally, about 1–3% of patients who initially do 
respond to steroids later become non-responders, 
or resistant to treatment.6 Most patients who do not 
achieve remission of proteinuria with steroids have 
kidney biopsy findings other than minimal change 
NS. Most cases fail to achieve remission with 
any treatment and progress to end-stage kidney 
disease.7,8
Chronic hyperlipidaemia has been linked to 
an increased risk of atherosclerosis and coronary 
artery disease, and has also been associated with 
the progression of renal disease.9 However, small 
studies that have been done of the effects of lipid-
lowering agents in paediatric INS have not shown 
an improvement in proteinuria or the progression 
of renal disease.2 The ABI test is a popular tool 
for the non-invasive assessment of PAD. Studies 
have shown the sensitivity of ABI is 90% with 
a corresponding 98% specificity for detecting 
haemodynamically significant  stenosis of >50% in 
major leg arteries as defined by angiogram.3
Our study on steroid-resistant NS proved that 
ABI scores in the patient group were significantly 
lower (0.89 ± 0.02) than in the control group (1.04 
± 0.08) (P <0.0001). This is related either to the 
nature of the disease and hyperlipidaemia, or to 
drugs used in treatment, such as corticosteroids. 
They both cause arterial stiffness and increase the 
risk of cardiovascular morbidity and mortality. 
They also predispose patients to rapid progression 
to end-stage kidney disease. Our results were in 
agreement with De Vinuesa et al. who investigated 
the prevalence of PAD using the ABI in 102 
patients who had been referred for the first time to 
a nephrology clinic with CKD. The study found a 
high prevalence of PAD (considered an ABI score of 
<0.9) in non-dialysed patients with CKD.10 Another 
study by Willenberg et al. focused on children with 
a history of longterm (>5 years) corticosteroid use 
(group A) and a matched control group without a 
history of corticosteroid use (group B). ABI scores 
showed that 80% in group A as compared to 9% in 
group B (P = 0.0009) were at risk of atherosclerosis. 
The results suggested that long-term corticosteroid 
therapy is associated with a distally accentuated 
calcifying atherosclerosis.11 In our study, ABI scores 
correlated well with the renal function of patients 
(P <0.001) so ABI could be a very easy way to 
predict early complications in these patients; for 
example, when renal markers (urea and creatinine) 
start to be affected, peripheral arterial assessment 
must be done. Our findings also agree with those 
of Kshirsagar et al. who found that the presence 
of an ABI score <0.90 was associated with an 
estimated glomerular filtration rate (GFR) of <90 
when compared to the reference group.12 In our 
study, serum phosphorus and alkaline phosphatase 
were significantly higher in the patient group 
versus the control group, (P value 0.01–0.03 and 
0.006, respectively) This finding agrees with that of 
Toussaint and Kerr who postulated that vascular 
calcification induced by calcium and phosphate 
excesses and uremia is a major risk factor and 
is independently associated with cardiovascular 
events and death.13 They also recommended that 
both vascular calcification and arterial stiffness 
can be measured through non-invasive techniques 
involving computed tomography (CT), ultrasound, 
echocardiography, and pulse wave velocity. 
Also in our study, there was a highly significant 
negative correlation between mean ABI score 
and cholesterol levels (P <0.001). There was also a 
significant negative correlation between mean ABI 
score and serum TG (P <0.02). These results were 
in agreement with those of An et al. who studied 
the relation between PAD and renal insufficiency 
in high risk cardiovascular patients and concluded 
that a high prevalence of PAD (defined as an ABI 
≤0.9) was associated with hypercholesterolaemia, 
CAD, and cerebrovascular diseases.14
Conclusion
The ABI is a simple, non-invasive bedside test 
for early detection of PAD, which is a marker 
of cardiovascular morbidity. Steroid-resistant 
NS patients are at high risk of developing 
cardiovascular complications, so early screening 
for PAD would be useful to prevent morbid 
complications. 
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